This post was originally published on this site
IDEXX Labs announced earnings per share of $1.83 on revenue of $801.09M. Analysts polled by Investing.com anticipated EPS of $1.72 on revenue of $781.83M.
IDEXX Labs shares are up 3% from the beginning of the year, still down 27.32% from its 52 week high of $706.51 set on August 4, 2021. They are outperforming the S&P 500 which is down 4.61% from the start of the year.
IDEXX Labs’s report follows an earnings beat by J&J on January 25, who reported EPS of $2.13 on revenue of $24.8B, compared to forecasts EPS of $2.12 on revenue of $25.28B.
UnitedHealth had beat expectations on January 19 with fourth quarter EPS of $4.48 on revenue of $73.74B, compared to forecast for EPS of $4.3 on revenue of $72.98B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
